Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1482 Articles

Lee Jackson | May 22, 2015 at 9:15 AM EDT

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

With major mergers and acquisition deals happening, and a host of clinical trials that could offer some outstanding breakthrough drug…

Paul Ausick | May 13, 2015 at 4:01 PM EDT

The 4 Stocks That Drove the DJIA Down on Wednesday

thinkstockMay 13, 2015: Markets opened higher on Wednesday but were able to eke out just modest gains by the end…

Chris Lange | May 12, 2015 at 9:50 AM EDT

Short Sellers Keep Strong Bets Against Big Pharma

The April 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Trey Thoelcke | May 12, 2015 at 6:28 AM EDT

The 5 Most Shorted NYSE Stocks in April

The five most shorted stocks trading on the New York Stock Exchange remained the same between the April 15 and…

Lee Jackson | May 8, 2015 at 9:20 AM EDT

4 Pharmaceutical Companies Leading the Breast Cancer Fight

In a new report, the RBC team focused on the companies that are making the most progress with treatments for…

Paul Ausick | May 6, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the DJIA on Wednesday

thinkstockMay 6, 2015: Markets opened higher on Wednesday but soon sank as growth expectations for the U.S. economy dimmed again.…

Chris Lange | May 5, 2015 at 10:50 AM EDT

Top Credit Suisse Major Pharma Stock Picks to Buy

Credit Suisse has released a report that detailed its top picks for pharmaceutical stocks for the rest of 2015.

Jon C. Ogg | Apr 29, 2015 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: AK Steel, NOV, Pfizer, Stratasys, Twitter, Wynn and More

Wednesday's top analyst upgrades, downgrades and initiations include AK Steel, National Oilwell Varco, Pfizer, Stratasys, Twitter and Wynn Resorts.

Jon C. Ogg | Apr 28, 2015 at 8:00 AM EDT

Pfizer Dodges a Bullet on Earnings

Pfizer has reported better-than-expected first-quarter earnings and revenue and offered guidance.

Paul Ausick | Apr 27, 2015 at 4:01 PM EDT

The 4 Stocks That Sank the DJIA on Monday

thinkstockApril 27, 2015: Markets opened higher on Monday but there was little positive news to sustain the opening gains. Biotech…

Chris Lange | Apr 27, 2015 at 3:22 PM EDT

What to Expect From Merck and Pfizer Earnings

Pharmaceutical giants Merck and Pfizer are both releasing their first quarter financial results early Tuesday.

Trey Thoelcke | Apr 27, 2015 at 6:45 AM EDT

The 5 Most Shorted NYSE Stocks as Q2 Begins

Rising short interest in Petrobras kept its shares firmly in ranks of the most shorted stocks trading on the New…

Chris Lange | Apr 26, 2015 at 9:15 AM EDT

7 DJIA Earnings Previews for This Week: Apple, Merck, Pfizer, Exxon, Visa, Chevron

24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average components reporting their financial…

Jon C. Ogg | Apr 17, 2015 at 8:10 AM EDT

The 5 Best DJIA Stocks of 2015 — With More Upside Expected

24/7 Wall St. wanted to review the five Dow stocks that are up the most so far this year. All…

Jon C. Ogg | Apr 14, 2015 at 12:15 PM EDT

Over Half of DJIA Stocks Outyield 30-Year Treasury Bond

The 30-year Treasury Bond yields only about 2.5% and, amazingly, more than half of the 30 Dow Jones Industrial Average…

1 … 59 60 61 62 63 … 99

Pfizer : PFE

All Pfizer Articles

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

The 4 Stocks That Drove the DJIA Down on Wednesday

Short Sellers Keep Strong Bets Against Big Pharma

The 5 Most Shorted NYSE Stocks in April

4 Pharmaceutical Companies Leading the Breast Cancer Fight

The 4 Stocks That Weighed on the DJIA on Wednesday

Top Credit Suisse Major Pharma Stock Picks to Buy

Top Analyst Upgrades and Downgrades: AK Steel, NOV, Pfizer, Stratasys, Twitter, Wynn and More

Pfizer Dodges a Bullet on Earnings

The 4 Stocks That Sank the DJIA on Monday

What to Expect From Merck and Pfizer Earnings

The 5 Most Shorted NYSE Stocks as Q2 Begins

7 DJIA Earnings Previews for This Week: Apple, Merck, Pfizer, Exxon, Visa, Chevron

The 5 Best DJIA Stocks of 2015 — With More Upside Expected

Over Half of DJIA Stocks Outyield 30-Year Treasury Bond

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

Pfizer : PFE

All Pfizer Articles

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

The 4 Stocks That Drove the DJIA Down on Wednesday

Short Sellers Keep Strong Bets Against Big Pharma

The 5 Most Shorted NYSE Stocks in April

4 Pharmaceutical Companies Leading the Breast Cancer Fight

The 4 Stocks That Weighed on the DJIA on Wednesday

Top Credit Suisse Major Pharma Stock Picks to Buy

Top Analyst Upgrades and Downgrades: AK Steel, NOV, Pfizer, Stratasys, Twitter, Wynn and More

Pfizer Dodges a Bullet on Earnings

The 4 Stocks That Sank the DJIA on Monday

What to Expect From Merck and Pfizer Earnings

The 5 Most Shorted NYSE Stocks as Q2 Begins

7 DJIA Earnings Previews for This Week: Apple, Merck, Pfizer, Exxon, Visa, Chevron

The 5 Best DJIA Stocks of 2015 — With More Upside Expected

Over Half of DJIA Stocks Outyield 30-Year Treasury Bond

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Featured Reads

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later